ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Director, Patient Operations at Beam Therapeutics - ApplyBlast

Director, Patient Operations

Beam Therapeutics

9 hours ago

4.1 on Glassdoor

Cambridge, Massachusetts, United States

Onsite

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Beam Therapeutics is seeking a Director, Patient Operations to optimize the delivery of risto-cel to Treatment Centers, focusing on Sickle Cell Disease and cell therapies. This role involves collaborating with cross-functional teams to define strategies for the end-to-end patient and product journey, from enrollment through treatment. The position requires developing team structures, setting operational targets, and ensuring effective communication and logistics for commercialization.

Responsibilities

Lead and develop a team of Case Managers and Logistics Managers
Define strategy and operational oversight of the end-to-end patient and product journey
Develop cell therapy cold-chain logistics, courier and vendor management processes

Skills

Qualifications

BSBAMBAMDPhD

About Beam Therapeutics

beamtx.com

Headquarters

Cambridge, Massachusetts, United States

Company Size

501-1000 employees

Founded

2017

View Profile

Beam Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, pioneering precision genetic medicines using its proprietary base editing platform to make precise single‑base DNA changes without creating double‑strand breaks. The company advances both in vivo and ex vivo programs across hematology, rare genetic diseases, and oncology, moving several candidates toward clinical development. Beam combines engineered editors, delivery technologies, and extensive safety profiling to create durable, potentially one‑time treatments and partners with academic and industry collaborators to accelerate translation.